id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-331517-o5ejfq86	Hirayama, Takehisa	Guillain-Barré syndrome after COVID-19 in Japan	2020-10-29		.txt	text/plain	2135	148	47	We report the first case of Guillain-Barré syndrome (GBS) associated with SARS-CoV-2 infection in Japan. In previous reports, most patients with SARS-CoV-2-infection-related GBS had lower limb predominant symptoms, and antiganglioside antibody tests were negative. Our findings support the notion that non-immune abnormalities such as hyperinflammation following cytokine storms and microvascular disorders due to vascular endothelial damage may lead to neurological symptoms in patients with SARS-CoV-2 infection. 4 In the present report, we discuss a case of axonal-type GBS associated with SARS-CoV-2 infection, where the patient was tested for various antiganglioside antibodies. Furthermore, we review the cases of SARS-CoV-2-infection-related GBS reported to date, in order to provide insight into the clinical characteristics and pathological mechanisms underlying the disease. In conclusion, our report supports the notion that patients with GBS associated with SARS-CoV-2 infection tend to test negative for antiganglioside antibodies. ► Patients with Guillain-Barré syndrome (GBS) associated with SARS-CoV-2 infection may test negative for many known antiganglioside antibodies.	./cache/cord-331517-o5ejfq86.txt	./txt/cord-331517-o5ejfq86.txt